Edition:
United States

Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

3.16USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$3.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
70,909
52-wk High
$3.40
52-wk Low
$1.11

Select another date:

Wed, Nov 8 2017

BRIEF-Sierra Oncology reports net loss $0.19 per share

* Qtrly ‍net loss per share, basic and diluted $0.19​ Source text for Eikon: Further company coverage:

BRIEF-Sierra Oncology appoints Dr. Andrew Allen to board

* Sierra Oncology appoints Dr. Andrew Allen to its board of directors Source text for Eikon: Further company coverage:

BRIEF-Sierra Oncology establishes DNA damage response advisory committee

* ‍sierra Oncology - establishes DNA damage response advisory committee​ Source text for Eikon: Further company coverage:

BRIEF-Sierra Oncology reports qtrly loss per share $‍0.20​

* ‍on track to provide preliminary update from CHK1 inhibitor SRA737 clinical trials in early 2018​

Select another date: